1. Introduction
Prior myocardial infarction is the most common cause of sustained ventricular tachycardia (VT). Management options include implantable defibrillators (ICDs), antiarrhythmic drugs, arrhythmia surgery, and catheter ablation [1], [2]. Although ICDs reduce mortality, they do not prevent recurrent VT, which occurs frequently in ICD recipients [3]–[5]. Catheter ablation has a role as an alternative or adjunct to pharmacologic therapy to prevent recurrent VT [6]. One such technique involves identification of the infarct substrate with pace-mapping around the edges of the infarcted myocardium [7], [8] until a match for QRS morphology of VT is seen. An intuitive interpretation of the surface ECG is required for this approach, which is often challenging. A technique to rapidly identify the scar exit sites of VT circuits could facilitate catheter ablation and direct more detailed point-by-point mapping. An endocardial array is available for this purpose, but is costly and requires the introduction of a large intracardiac balloon-mounted array [9].